This prospective study was designed to explore the prevalence and the clinical and prognostic significance of anticardiolipin (ACL) antibodies in patients with acute myeloid leukemia (AML). The study includes 37 consecutive AML patients >15 years old without previous history of thromboembolism, recu
Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemia
โ Scribed by Dr. Azra Raza; Harvey Preisler; Beatrice Lampkin; Joseph Lykins; Cathy Kukla; Peter Gartside; Yasin Sheikh; Naveed Yousuf; Michael White; Maurice Barcos; John Bennett; George Browman; Jack Goldberg; Hans Grunwald; Richard Larson; James Vardiman; Ralph Vogler
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 1023 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Acute myeloid leukemia (AML) is a malignant disease of hematopoietic cells whose emergence, course, and prognosis is affected by specific recurrent genetic alterations like chromosome aberrations and point mutations, as well as by changes in the expression of certain genes. In the past
CD7 antigen, a T-cell lineage associated antigen, is expressed in a minority of patients with acute myeloid leukemia (AML). The biologic and clinical significance of this finding is not clearly established. In this retrospective study of patients with de novo acute myeloid leukemia, we have identifi